🇺🇸 FDA
Patent

US 8946176

Compositions and methods for inhibiting expression of RRM2 genes

granted A61KA61K48/00A61P

Quick answer

US patent 8946176 (Compositions and methods for inhibiting expression of RRM2 genes) held by Arrowhead Research Corporation expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Research Corporation
Grant date
Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K48/00, A61P, A61P35/00